NCT04438382 2026-02-27
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Eastern Cooperative Oncology Group
Phase 2 Terminated
Clinical Trials
3 trialsNCT00897312 2016-04-25
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Vanderbilt-Ingram Cancer Center
Terminated
NCT00325078 2015-12-29
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated